PharmaShots | Incisive News in 3 Shots

Subscribe Now

InflaRx

InflaRx Report EMA’s Validation of MAA for Vilobelimab to Treat Critically Ill COVID-19 Patients

InflaRx Report EMA’s Validation of MAA for Vilobelimab to Treat Critically Ill COVID-19 Patients

August 30, 2023

InflaRx Receives the US FDA’s EUA for Gohibic (vilobelimab) to Treat COVID-19

InflaRx Receives the US FDA’s EUA for Gohibic (vilobelimab) to Treat COVID-19

April 5, 2023

InflaRx Reports Results of Vilobelimab in the P-III Part of P-II/III (PANAMO) Study for the Treatment of Severe COVID-19

InflaRx Reports Results of Vilobelimab in the P-III Part of P-II/III (PANAMO) Study for the Treatment of Severe COVID-19

April 1, 2022

PharmaShots Weekly Snapshots (May 10 - 14, 2021)

PharmaShots Weekly Snapshots (May 10 - 14, 2021)

May 14, 2021

Insights+: COVID-19 Healthcare News Monthly Updates - June 2020

Insights+: COVID-19 Healthcare News Monthly Updates - June 2020

June 30, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us